Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,424 across all filing types
Latest filing 2025-02-20 Declaration of Voting R…
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed communication addressed to stock exchanges regarding the voting results of a postal ballot for the appointment of an independent director. It includes the voting results, scrutinizer's report, references to relevant regulations (SEBI Listing Regulations, Companies Act, and MCA Circulars), and confirms the resolution was passed. The content is focused on the official announcement of voting outcomes and the scrutinizer's certification of the voting process, not the meeting materials or the full AGM report. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length and detail confirm it is not a brief announcement or a simple notice but a full voting result report. Therefore, the correct classification is DVA with high confidence.
2025-02-20 English
Postal Ballot-Scrutinizer''s Report
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is an official announcement to stock exchanges reporting the voting results of a postal ballot (remote e-voting) pursuant to SEBI Listing Regulations and includes the Scrutinizer’s report. It is not a proxy solicitation, AGM presentation, or a full financial report. It clearly fits the definition of Declaration of Voting Results & Voting Rights Announcements.
2025-02-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for the third quarter and nine months ended December 31, 2024, for Sequent Scientific Limited. It includes management commentary, financial performance highlights, discussion of merger progress, and Q&A format typical of earnings call transcripts. The text references unaudited financial results, mentions the earnings call date, and includes multiple speakers from management discussing financial results and business updates. There is no indication that this is a brief announcement or a report publication notice; rather, it is the full transcript of the earnings call. Therefore, the document fits the definition of a Call Transcript (CT).
2025-02-17 English
Earning transcript Q3 FY25
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for the third quarter and nine months ended December 31, 2024, for Sequent Scientific Limited. It includes management commentary, financial performance highlights, discussion of merger progress, and Q&A format typical of earnings call transcripts. The text references unaudited financial results, mentions the earnings call date, and includes detailed financial metrics and forward-looking statements. It explicitly states it is a transcript of the Q3 FY25 earnings call. Therefore, the document fits the category of a Call Transcript (CT). The document length (15,000 characters) and content confirm it is the full transcript, not just an announcement or summary. Confidence is high due to clear identification and content type.
2025-02-17 English
Audio Recording of Earnings call pertaining to the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2024
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording of an earnings call for the quarter and nine months ended December 31, 2024. It references the unaudited financial results and provides a link to the audio recording of the earnings call. The document does not contain the financial results themselves but is an announcement about the availability of the earnings call recording. The document length is short (1864 characters), and it serves as a notification rather than the full transcript or report. Therefore, it fits best under the category of Call Transcript (CT) since it pertains to the earnings call, but since it only announces the audio recording and does not contain the transcript itself, it is more appropriate to classify it as a Regulatory Filing (RNS) as a general announcement related to regulatory compliance and disclosure of earnings call audio recording.
2025-02-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is a short communication from Sequent Scientific Limited addressed to stock exchanges regarding the audio recording of an earnings call for the quarter and nine months ended December 31, 2024. It references the unaudited financial results and provides a link to the audio recording of the earnings call. The document does not contain actual financial data or detailed financial statements but is an announcement about the availability of the earnings call recording. The length is only 1864 characters, which is quite short and fits the pattern of an announcement rather than the full earnings release or transcript. According to the rules, announcements about earnings calls or their recordings are best classified as Call Transcript (CT) if they contain the full transcript, but this document only announces the availability of the audio recording and does not contain the transcript itself. It is not a report publication announcement (RPA) because it is specifically about the earnings call audio recording, which is a call transcript related document. Given the content, the best fit is Call Transcript (CT) with moderate confidence because it is about the earnings call audio recording, which is part of call transcripts.
2025-02-13 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.